Could a common food preservative help treat Hard-to-Treat schizophrenia?
NCT ID NCT06340789
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding sodium benzoate—a substance that affects brain glutamate—to standard antipsychotic medication can improve symptoms and thinking in people with treatment-resistant schizophrenia. About 90 adults who have not responded well to at least two antipsychotics will receive either sodium benzoate or a placebo for 8 weeks. Researchers will use brain scans, blood tests, and symptom ratings to see if the treatment works and to identify who might benefit most.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sodium benzoate
- What this could lead to
- If it works, this could offer a new add-on treatment option for people with schizophrenia who do not respond to standard antipsychotics.
- What could go wrong
- This is a Phase 2 trial with 90 participants, so results are still early. Sodium benzoate may not improve symptoms more than placebo, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZO AFFECTIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Taichung Veterans General Hospital Chiayi Branch
RECRUITINGChiayi City, 600, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Can a new daily pill offer safer Long-Term control of schizophrenia?
- Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?
- Can a dissolving film tame agitation in schizophrenia?
- Can a phone app teach the brain to read social cues?
- Can a gentle brain current silence voices that medication Can't?